PATENT CLAIM ANALYSIS

Application Number: 16113924
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "234100"]

Abstract:
A vaccine includes at least one bacterial antigen capable of producing an immune response in a host when the vaccine is administered at a dose that is sufficient for preventing or treating Q fever in the host. The vaccine composition confers immunity against Q fever without the reactogenic side effects observed in prior art vaccines.

Claim (Index 2):
The vaccine composition of  claim 1 , wherein the bacterial extract is derived from  Coxiella burnetii.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 96.0
- Lexical Diversity: 1.29545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14338730', '15195586', '11401013', '12001599', '12001598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6878190456018061
- 35 USC 102 Novelty (BERT): 0.4948176564127265
- Combined Prediction Score: 0.668518906682898
- Mean Citation Score: 181.216372
- Max Citation Score: 197.34299
- Similarity Product: 141.37661751901746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test